Top 10 Companies in the Global Chitosan and Chitosan Derivatives Market (2026): Market Leaders Powering Global Applications

MARKET INSIGHTS

The Global Chitosan and Chitosan Derivatives Market size was valued at USD 1.9 billion in 2024. The market is projected to grow from USD 2.1 billion in 2025 to USD 3.8 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period.

Chitosan and its derivatives are natural biopolymers derived primarily from chitin, a structural component found in crustacean shells. These versatile biomaterials are characterized by their biodegradability, biocompatibility, and non‑toxicity, making them suitable for a wide range of applications. Key chitosan derivatives include chitosan oligosaccharides, carboxymethyl chitosan, and chitosan hydrochloride, each offering unique functional properties tailored to specific industry needs.

The market is experiencing robust growth driven by increasing demand across pharmaceutical, food, cosmetic, and water treatment industries. Rising adoption in wound healing, drug delivery systems, and dietary supplements is a significant growth factor. Furthermore, advancements in production technologies and growing emphasis on sustainable, bio‑based materials are contributing to market expansion. Key players such as Primex, FMC Corporation, and Kitozyme are actively investing in R&D and strategic partnerships to enhance their product portfolios and market presence.

Global Chitosan and Chitosan Derivatives Market – View in Detailed Research Report

Top 10 Companies in the Global Chitosan and Chitosan Derivatives Market (2026)

🔟 1. Primex EHF

Headquarters: Reykjavik, Iceland
Key Offering: High‑purity chitosan for pharmaceutical and cosmetic applications

Primex EHF has positioned itself as a leader in the production of premium chitosan by leveraging advanced deacetylation processes that ensure consistent molecular weight and low heavy‑metal content. The company supplies both raw chitosan and specialized derivatives such as chitosan oligosaccharides used in drug delivery systems and nutraceuticals.

Sustainability Initiatives:

• Integration of closed‑loop water systems to reduce chemical usage during extraction
• Partnerships with Icelandic seafood processors to secure a steady supply of shell waste
• Certification of all products under ISO 9001 and ISO 14001

9️⃣ 2. FMC Corporation

Headquarters: Troy, Michigan, USA
Key Offering: Medical‑grade chitosan, chitosan derivatives for drug delivery and wound care

FMC Corporation’s health segment focuses on high‑quality chitosan for pharmaceutical and biomedical applications. Their portfolio includes chitosan hydrochloride for controlled‑release drug formulations and chitosan oligosaccharides for immunomodulatory therapies.

Sustainability Initiatives:

• Investment in enzymatic deacetylation to lower energy consumption
• Strategic acquisitions of niche biopolymer companies to expand derivative offerings
• Commitment to achieving net‑zero emissions by 2045

8️⃣ 3. Novamatrix (FMC Health & Nutrition)

Headquarters: Stavanger, Norway
Key Offering: Food‑grade chitosan and functional derivatives for nutraceuticals

Novamatrix specializes in chitosan formulations that meet stringent food‑grade standards. Their products are used as natural preservatives, edible film coatings, and cholesterol‑lowering supplements.

Sustainability Initiatives:

• Use of renewable energy sources in production facilities
• Collaboration with Nordic seafood cooperatives to optimize waste utilization
• Transparent supply chain tracking via blockchain

7️⃣ 4. Kitozyme S.A.

Headquarters: Antwerp, Belgium
Key Offering: Medical‑grade chitosan for wound dressings and hemostatic agents

Kitozyme focuses on delivering high‑purity chitosan for critical medical applications. Their product line includes chitosan hydrogels used in advanced wound care and blood‑clotting aids.

Sustainability Initiatives:

• Zero‑waste manufacturing processes
• Partnership with European research institutes on biodegradable biomaterials
• Certification under EU Green Deal standards

6️⃣ 5. Heppe Medical Chitosan GmbH

Headquarters: Hamburg, Germany
Key Offering: Clinical‑grade chitosan for tissue engineering and drug delivery

Heppe Medical Chitosan supplies ultra‑pure chitosan used in scaffolds for regenerative medicine and as a carrier for targeted drug delivery. Their rigorous quality controls meet European pharmacopeia requirements.

Sustainability Initiatives:

• Use of biobased solvents in purification steps
• Active participation in EU Horizon 2020 projects on sustainable biopolymers
• Carbon‑neutral production goal by 2030

5️⃣ 6. Golden Shell Pharmaceutical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Cost‑effective chitosan for pharmaceutical and cosmetic applications

Golden Shell leverages China’s abundant shrimp and crab shell waste to produce high‑yield chitosan. Their products are used in drug delivery systems, wound dressings, and cosmetic formulations.

Sustainability Initiatives:

• Implementation of energy‑efficient deacetylation units
• Collaboration with local fisheries to ensure responsible sourcing
• ISO 14001 certification for environmental management

4️⃣ 7. Kunpoong Bio Co., Ltd.

Headquarters: Seoul, South Korea
Key Offering: Advanced chitosan derivatives for nutraceuticals and cosmetics

Kunpoong Bio focuses on high‑purity chitosan derivatives that enhance skin moisturization and provide antioxidant benefits in personal care products.

Sustainability Initiatives:

• Use of green extraction technologies
• Partnership with Korean food safety authorities to certify food‑grade products
• Commitment to reduce CO₂ emissions by 25% by 2035

3️⃣ 8. Advanced Biopolymers AS

Headquarters: Oslo, Norway
Key Offering: Industrial‑grade chitosan for chemical and environmental applications

Advanced Biopolymers supplies chitosan for use in flocculants, water treatment, and polymer blends. Their products are known for consistent performance and scalability.

Sustainability Initiatives:

• Adoption of renewable energy sources in manufacturing
• Research into fungal‑based chitosan to diversify supply
• ISO 9001 certification for quality management

2️⃣ 9. Qingdao Honghai Bio‑tech Co., Ltd.

Headquarters: Qingdao, China
Key Offering: Food‑grade chitosan and functional derivatives for the food industry

Qingdao Honghai provides chitosan used as natural preservative and edible film coating, extending shelf life of fresh produce and packaged foods.

Sustainability Initiatives:

• Implementation of zero‑liquid‑discharge processes
• Collaboration with local seafood processors for waste valorization
• Compliance with China’s “Green Food” certification standards

1️⃣ 10. Zhejiang New Fuda Ocean Biotech Co., Ltd.

Headquarters: Zhejiang, China
Key Offering: High‑purity chitosan for pharmaceutical and cosmetic applications

Zhejiang New Fuda focuses on producing pharmaceutical‑grade chitosan with stringent purity controls, catering to global drug delivery and cosmetic markets.

Sustainability Initiatives:

• Use of low‑energy extraction methods
• Partnership with Chinese environmental agencies for waste management
• ISO 14001 certification for environmental performance

Download FREE Sample Report: Global Chitosan and Chitosan Derivatives Market – View in Detailed Research Report

Get Full Report: Global Chitosan and Chitosan Derivatives Market – View in Detailed Research Report

Outlook: The Future of Global Chitosan and Chitosan Derivatives Market

With a projected CAGR of 9.5% from 2025 to 2032, the market is set to expand from USD 2.1 billion to USD 3.8 billion. Growth will be driven by the increasing adoption of chitosan in pharmaceutical drug delivery, wound care, and nutraceuticals, as well as its expanding role in water treatment and food preservation. Regulatory trends favoring biodegradable and sustainable materials, coupled with technological advances in extraction and purification, will further accelerate market penetration across high‑value segments.

Key Trends Shaping the Market:

• Shift toward bio‑based, sustainable biopolymers in consumer and industrial applications.
• Rapid development of chitosan‑based drug delivery systems and advanced wound‑healing products.
• Expansion of water‑treatment solutions using chitosan as a cost‑effective flocculant.
• Growing interest in non‑crustacean sources such as fungi and algae to diversify supply chains.
• Increased investment in high‑purity, clinical‑grade chitosan for premium pharmaceutical and cosmetic markets.